These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 23106507

  • 41. [In vitro activity of linezolid and dalbavancin against vancomycin-resistant enterococci].
    Aktaş G, Bozdoğan B, Derbentli S.
    Mikrobiyol Bul; 2012 Jul; 46(3):359-65. PubMed ID: 22951648
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
    Fontana R, Ligozzi M, Mazzariol A, Veneri G, Cornaglia G.
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S84-6. PubMed ID: 9710675
    [Abstract] [Full Text] [Related]

  • 44. Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe.
    Kuch A, Willems RJ, Werner G, Coque TM, Hammerum AM, Sundsfjord A, Klare I, Ruiz-Garbajosa P, Simonsen GS, van Luit-Asbroek M, Hryniewicz W, Sadowy E.
    J Antimicrob Chemother; 2012 Mar; 67(3):551-8. PubMed ID: 22207599
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. In vitro evaluation of antibiotics in the treatment of periodontal disease.
    Mashimo PA, Yamamoto Y, Slots J, Evans RT, Genco RJ.
    Pharmacol Ther Dent; 1981 Mar; 6(1-2):45-56. PubMed ID: 6941319
    [Abstract] [Full Text] [Related]

  • 47. Antimicrobial resistance of Enterococci in Lebanon.
    Zouain MG, Araj GF.
    Int J Antimicrob Agents; 2001 Mar; 17(3):209-13. PubMed ID: 11282266
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Susceptibility profile of Enterococcus faecalis isolated at the Lagos University Teaching Hospital, Nigeria.
    Iregbu KC, Ogunsola FT, Odugbemi TO.
    Niger Postgrad Med J; 2002 Sep; 9(3):125-8. PubMed ID: 12501265
    [Abstract] [Full Text] [Related]

  • 50. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A, Baltch AL, Ritz WJ, Smith RP, Asperilla M.
    Chemotherapy; 1993 Sep; 39(5):302-9. PubMed ID: 8396526
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Antimicrobial susceptibility and molecular analysis of Enterococcus faecalis originating from endodontic infections in Finland and Lithuania.
    Reynaud Af Geijersstam AH, Ellington MJ, Warner M, Woodford N, Haapasalo M.
    Oral Microbiol Immunol; 2006 Jun; 21(3):164-8. PubMed ID: 16626373
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
    Tomás I, Tomás M, Alvarez M, Velasco D, Potel C, Limeres J, Diz P.
    Oral Microbiol Immunol; 2007 Oct; 22(5):298-303. PubMed ID: 17803626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.